Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
06/27/2002 | CA2431139A1 Oxidoreductases |
06/27/2002 | CA2430918A1 Compounds that affect cd83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds |
06/27/2002 | CA2430754A1 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
06/27/2002 | CA2430595A1 Dissociated glucocorticoid receptor antagonists for the treatment of glucocorticoid associated side-effect |
06/27/2002 | CA2406028A1 Method for testing for allergic disease |
06/27/2002 | CA2400281A1 Electrochemical test strip cards that include an integral dessicant |
06/27/2002 | CA2327581A1 Methods and compositions for the establishment of genetically altered cell-based library designed for monitoring transcriptional activity of compounds and molecules |
06/27/2002 | CA2327527A1 Method for the normalization of the relative fluorescence intensities of two rna samples in hybridization arrays |
06/26/2002 | EP1217379A2 Method for determining the ion concentration of blood and dialysis apparatus |
06/26/2002 | EP1217378A1 Detection of advanced glycation endproducts in a cerebrospinal fluid sample |
06/26/2002 | EP1217377A2 Process for the specific detection of tumour cells and their precursors in cervical smears through simultaneous measurement of at least two different molecular markers |
06/26/2002 | EP1217376A1 Beads |
06/26/2002 | EP1217375A1 Solid phase substrate for structured reaction substrates |
06/26/2002 | EP1217374A1 Method of determining the iodine content in biological fluids, and semiautomatic apparatus for carrying out the same |
06/26/2002 | EP1217372A1 Improved flow cytometry reagent and system |
06/26/2002 | EP1217371A1 An improved method for quantitative assessment of anthropogenic compounds in soil |
06/26/2002 | EP1217362A1 NOx reduction sensor coating |
06/26/2002 | EP1217360A2 Use of styrene based syndiotactic polymers as sensing elements for detection of organic pollutants |
06/26/2002 | EP1217355A2 A gas sample chamber system |
06/26/2002 | EP1217102A2 Plating apparatus and method of managing plating liquid composition |
06/26/2002 | EP1217080A2 Methods, compositions and kits relating to cardiovascular disease |
06/26/2002 | EP1217078A1 Phosphatase immunoassay using antibodies against bisphosphorylated substrates |
06/26/2002 | EP1217068A2 Oil palm (genus Elaeis) peroxiredoxin gene and uses thereof |
06/26/2002 | EP1217007A2 Serum paraoxonase |
06/26/2002 | EP1216994A2 Tricyclic antidepressant derivatives and immunoassay |
06/26/2002 | EP1216754A1 Reaction receptacle apparatus |
06/26/2002 | EP1216707A1 New therapeutic uses of a SMR-1-peptide |
06/26/2002 | EP1216622A2 Method of adaptation of aroma mixtures |
06/26/2002 | EP1216417A1 Quantitative analysis and typification of subcellular particles |
06/26/2002 | EP1216416A1 Test device |
06/26/2002 | EP1216415A1 Methods for determining oils in seeds |
06/26/2002 | EP1216411A1 Method and device for detecting a molecular recognition reaction |
06/26/2002 | EP1216410A1 Method and device for analysing nucleic acids immobilised on a support |
06/26/2002 | EP1216408A1 System for processing and imaging of samples |
06/26/2002 | EP1216310A1 Affinity sensor for the detection of biological and/or chemical species and use thereof |
06/26/2002 | EP1216309A2 Methods for targeting rna molecules |
06/26/2002 | EP1216307A2 Method for the detection of antimicrobial residues |
06/26/2002 | EP1216300A1 Methods and compositions relating to sodium channel beta1a subunits |
06/26/2002 | EP1216297A2 Double transgenic animals as models for neurodegenerative disease |
06/26/2002 | EP1216259A1 SIGNAL SEQUENCES FOR THE PRODUCTION OF LEU-HIRUDINE VIA SECRETION BY i E. COLI /i IN A CULTURE MEDIUM |
06/26/2002 | EP1216258A1 Factors having prion-binding activity in serum and plasma and agents to detect transmissible spongiform encephalopathitis |
06/26/2002 | EP1216255A1 Method for nucleic acid isolation and kit |
06/26/2002 | EP1216099A1 Internal adapter with a pellet well for a centrifuge container |
06/26/2002 | EP1216060A2 Magnetic nanoparticles having biochemical activity, method for the production thereof and their use |
06/26/2002 | EP1215959A1 Methods for evaluating a compound for its effect on skin |
06/26/2002 | EP1185948A4 Method for screening and producing compound libraries |
06/26/2002 | EP1028651A4 Fluid and electrolyte balance monitoring system for surgical and critically ill patients |
06/26/2002 | EP1005652A4 Antigens embedded in thermoplastic |
06/26/2002 | EP1002233A4 High-throughput assay |
06/26/2002 | EP0980439A4 Pan-bacterial and pan-fungal identification reagents and methods of use thereof |
06/26/2002 | EP0934429A4 Chronic fatigue syndrome diagnosis |
06/26/2002 | EP0912895A4 Method for monitoring t-cell reactivity |
06/26/2002 | EP0908453B1 Water-soluble tetrazolium salt compounds |
06/26/2002 | EP0907888B1 Molecule-marking method |
06/26/2002 | EP0901627B1 Reusable, planar sample analyser |
06/26/2002 | EP0894241B1 Apparatus and method for characterizing fiber crimps |
06/26/2002 | EP0892926B1 Method and apparatus for the measurement of components of exhaled breath in humans |
06/26/2002 | EP0865486A4 Stable biotinylated biomolecule composition and methods |
06/26/2002 | EP0574391B1 Antibodies against the urokinase receptor and their use |
06/26/2002 | EP0464147B1 Matrix metalloproteinase inhibitor peptides |
06/26/2002 | CN2497313Y Protein chip |
06/26/2002 | CN2497307Y Rapid checking card of bacterial vaginal disease |
06/26/2002 | CN2497305Y Dry-type multinomial urine test paper |
06/26/2002 | CN1355888A Method for assessing risk of peptic ulcer, comprising steps of determining quantitatively concentrations of pepsinogen I(PGI) and gastrin-17 in a serum sample |
06/26/2002 | CN1355887A Measuring method |
06/26/2002 | CN1355886A Method for identifying pre-neoplastic and/or neoplastic state in mammals |
06/26/2002 | CN1355885A Method for predicting and/or diagnosing risk of gastric cancer |
06/26/2002 | CN1355884A Fluorescence polarization assays involving polyions |
06/26/2002 | CN1355883A Encoding of microcarriers |
06/26/2002 | CN1355882A Method for quantifying transforming growth factor-beta 1 and method for detecting cancer by using same |
06/26/2002 | CN1355881A Growth differentiation factor inhibitors and uses therefor |
06/26/2002 | CN1355880A 生物传感器 Biosensor |
06/26/2002 | CN1355852A T cell receptor Vbeta-Dbeta-Jbeta sequence and methods for its detection |
06/26/2002 | CN1355845A PrP-like gene |
06/26/2002 | CN1355844A Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
06/26/2002 | CN1355813A Peptide having preptin functionality |
06/26/2002 | CN1355706A 因子 Factor |
06/26/2002 | CN1355705A Method of identifying therapeutic compounds for treatment of hepatic disorders |
06/26/2002 | CN1355429A Portable tester of dioxin compound |
06/26/2002 | CN1355428A Based on rhodamine fluorogen effective used as labeled reagent |
06/26/2002 | CN1355427A Process for testing concentration of polyacrylamide |
06/26/2002 | CN1086729C Fluorescent petroleum markers |
06/25/2002 | US6411905 Method and apparatus for estimating odor concentration using an electronic nose |
06/25/2002 | US6411834 Biological sensor |
06/25/2002 | US6411832 Method of improving reproducibility of non-invasive measurements |
06/25/2002 | US6410824 Animal model for psoriasis for the prevention and treatment of psoriasis in humans |
06/25/2002 | US6410775 APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies |
06/25/2002 | US6410751 Water soluble tri-substituted 1, 2-dioxetane compounds having increased storage stability, synthetic processes and intermediates |
06/25/2002 | US6410720 Compounds and methods for treatment and diagnosis of mycobacterial infections |
06/25/2002 | US6410715 Methods for treating hormone disorders |
06/25/2002 | US6410709 Polypeptide; for use in diagnosis and treatment of inflammatory and cell proliferative disorders |
06/25/2002 | US6410708 Nucleotide sequences coding preferential protein for use in the diagnosis and treatment of inflammation, cancer and inflammatory bowel disease |
06/25/2002 | US6410696 Cyclosporin immunoassay |
06/25/2002 | US6410688 Def1 |
06/25/2002 | US6410687 Polypeptide; for use as antiproliferative agents |
06/25/2002 | US6410686 Galanin receptor 2 protein |
06/25/2002 | US6410675 Functionalized silicon compounds and methods for their synthesis and use |
06/25/2002 | US6410587 Compounds and therapies for the prevention of vascular and non-vascular pathologies |
06/25/2002 | US6410516 Nuclear factors associated with transcriptional regulation |
06/25/2002 | US6410507 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |